Pacira (PCRX) BioSciences announced the appointment of Shawn Cross as Chief Financial Officer. In this role, Cross will be responsible for overseeing all aspects of the company’s financial operations. Cross brings more than 25 years of experience as a biotechnology executive, board member and investment banker. Prior to joining Pacira, Cross served at Applied Molecular Transport
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira reports inducement grants under Nasdaq listing rule
- Pacira announces product-specific J-Code for EXPAREL effective Jan. 1
- Pacira completes acquisition of pharmacy business in Atlantic Canada
- Pacira Pharmaceuticals Announces CFO Transition and Interim Replacement
- Pacira presents 104-week safety, efficacy data following PCRX-201 administration